关注
Mohammad Hadi Abbasian
Mohammad Hadi Abbasian
在 nigeb.ac.ir 的电子邮件经过验证
标题
引用次数
引用次数
年份
Global landscape of SARS-CoV-2 mutations and conserved regions
MH Abbasian, M Mahmanzar, K Rahimian, B Mahdavi, S Tokhanbigli, ...
Journal of Translational Medicine 21 (1), 152, 2023
392023
Association of interleukin-1 gene polymorphism with risk of gastric and colorectal cancers in an Iranian population
MH Abbasian, B Abbasi, N Ansarinejad, A Motevalizadeh Ardekani, ...
Iranian Journal of Immunology 15 (4), 321-328, 2018
182018
The role of dihydropyrimidine dehydrogenase and thymidylate synthase polymorphisms in fluoropyrimidine-based cancer chemotherapy in an Iranian population
MH Abbasian, N Ansarinejad, B Abbasi, M Iravani, T Ramim, F Hamedi, ...
Avicenna journal of medical biotechnology 12 (3), 157, 2020
152020
The role of genomics and proteomics in lung cancer early detection and treatment
MH Abbasian, AM Ardekani, N Sobhani, R Roudi
Cancers 14 (20), 5144, 2022
102022
Investigation of the relationship between monocyte chemoattractant protein 1 rs1024611 variant and severity of COVID-19
F Azarfar, B Abbasi, A Jalali, MH Abbasian
Cytokine 171, 156367, 2023
12023
Evaluation of the association between clinical parameters and ADAM33 and ORMDL3 asthma gene single-nucleotide polymorphisms with the severity of COVID-19
M Khoramipour, A Jalali, B Abbasi, MH Abbasian
International Immunopharmacology 123, 110707, 2023
12023
Methylenetetrahydrofolate Reductase C677T (rs1801133) Polymorphism and Pemetrexed Treatment Outcome in Patients with Non–Small-Cell Lung Cancer
MH Abbasian, N Ansarinejad, T Ramim, F Fardad, B Abbasi
Personalized Medicine Journal, 2021
12021
SLC19A1 and Thymidylate Synthase Polymorphisms Do not Predict Survival Outcome in Non-Small-Cell Lung Cancer Treated with Pemetrexed-Cisplatin Chemotherapy Regimen
MH Abbasian, N Ansarinejad, T Ramim, F Fardad, B Abbasi
Middle East Journal of Cancer 14 (1), 73-80, 2023
2023
系统目前无法执行此操作,请稍后再试。
文章 1–8